Vanda Pharmaceuticals Inc (VNDA) — Cash Flow Quality Index
Vanda Pharmaceuticals Inc (VNDA) has a Cash Flow Quality Index of -14.96x as of September 2023. Operating cash flow of $-2.05 Million is below net income of $137.00K, suggesting accrual-heavy earnings not yet converted to cash. Explore Vanda Pharmaceuticals Inc (VNDA) cash conversion ratio to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Vanda Pharmaceuticals Inc Cash Flow Quality Index (2010–2023)
Historical Cash Flow Quality Index for Vanda Pharmaceuticals Inc across 8 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check cash flow reinvestment rate of Vanda Pharmaceuticals Inc to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Vanda Pharmaceuticals Inc (2010–2023)
Year-by-year earnings quality comparison for Vanda Pharmaceuticals Inc. For live market cap and the full company financial profile, see Vanda Pharmaceuticals Inc (VNDA) market capitalisation.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | 5.10x | $12.80 Million | $2.51 Million | ▲ +0.1% |
| 2022 | 5.10x | $31.98 Million | $6.28 Million | ▲ +163.1% |
| 2021 | 1.94x | $64.21 Million | $33.15 Million | ▼ -12.7% |
| 2020 | 2.22x | $51.77 Million | $23.34 Million | ▲ +458.0% |
| 2019 | 0.40x | $45.95 Million | $115.55 Million | ▼ -66.6% |
| 2018 | 1.19x | $29.99 Million | $25.21 Million | ▲ +129.4% |
| 2014 | -4.04x | $-81.55 Million | $20.19 Million | ▼ -166.6% |
| 2010 | -1.52x | $-10.90 Million | $7.19 Million | — |